RNU6-1003P

Across TCGA pan-cancer cohorts, RNU6-1003P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-1003P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU6-1003P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1003P expression acts as an unfavorable survival marker.

TGCT, MESO, and KIRC are the cancer types where RNU6-1003P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	90	view →
MESO	OS	Tertile	All	0.180	0.562	.005	54	view →
KIRC	DFS	Tertile	IV	0.110	0.640	.001	42	view →
GBM	OS	Tertile	All	0.200	0.434	<.001	36	view →
SKCM	OS	Tertile	All	0.134	0.344	.008	18	view →
LIHC	OS	Tertile	All	0.122	0.704	.009	18	view →
DLBC	OS	Tertile	All	0.448	0.942	.013	12	view →
BRCA	DFS	Tertile	II,III,IV	0.874	0.944	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-1003P–TGCT (OS)

Open the TGCT breakdown →